ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. It offers YourBiotix CH and InstaMelt, capsule formula which contains LPLDL for maintenance of healthy cholesterol; YourBiotix BP, a blood pressure-reducing tablet formula for hypertension and cardiovascular health; and YourBiotix VH, a vascular health capsule formula, indicated to work against the build-up of lipid and calcium deposits in the blood vessels. The company was formerly known as ProBiotix Health Limited and changed its name to ProBiotix Health Plc in February 2022. The company was incorporated in 2021 and is based in Wakefield, the United Kingdom.
Metrics to compare | X90 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipX90PeersSector | |
---|---|---|---|---|
P/E Ratio | −20.7x | −3.3x | −0.7x | |
PEG Ratio | −1.70 | −0.02 | 0.00 | |
Price / Book | 8.0x | 2.3x | 2.6x | |
Price / LTM Sales | 4.8x | 11.9x | 3.2x | |
Upside (Analyst Target) | - | 222.6% | 46.6% | |
Fair Value Upside | Unlock | 18.9% | 7.4% | Unlock |